Is There a Way to Reduce the Need for Permanent Pacemaker Implantation in Self-Expanding Valves?

We are well aware of the benefits of TAVR in different scenarios, but the need for permanent pacemaker implantation (PPI) in self-expandable valves is between 15% and 30% according to different randomized and non-randomized studies.

¿Cómo podemos disminuir la necesidad de implante de marcapasos definitivo en las válvulas autoexpandibles?

This is why the higher implantation strategy or cusp overlap (COT) was developed and, though it has been shown to significantly reduce the need for PPI, so far, no randomized studies have looked into it. 

This study included 2209 patients with severe symptomatic aortic stenosis receiving self-expandable supra-annular valves from Medtronic (Evolut R, Evolute Pro and Evolute Pro+). 1151 of these patients were treated with the standard three-cusp implantation technique (3CT) (52.1%) and 1058 with the COT strategy.

Primary end point was need for PPI at discharge. 

Mean age was 82 and 54% of the population were women. After propensity score matching to balance for differences, 995 patients were left in each group. 

STS score was 3.6%, 96% was femoral, 91% under conscious sedation.

Read also: Drug-Eluting Balloon in STEACS: Leaving No Trace is Beneficial?

Procedural time was lower with COT, as was fluoroscopy time.

Pre and post-dilation were more frequent with COT, as was oversizing. Contrast volume was lower with COT.

PPI resulted in favor of COT in both the general and the matched population, 12.3% vs. 17% p=0.002 and 11.9% vs 17% p=0.001 respectively. New left bundle branch block was more frequent with COT (27.5% vs 22.6% p=0.01), and there were no differences in right bundle branch block. 

There were no differences in major complications.

Read also: Benefits of Distal Radial Access.

Severe and moderate paravalvular regurgitation were significantly lower in patients treated with COT (4.6% vs. 2.4% p=0.006).

In multivariable logistic regression, right bundle branch block and diabetes resulted predictors of PPI and COT resulted protective. 

Conclusion

COT was associated with significant reduction of PPI and paravalvular regurgitation with no increase in complications. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Cusp overlap versus standard three-cusp technique for selfexpanding Evolut transcatheter aortic valves.

Reference: Hendrik Wienemann, et al.  EuroIntervention 2023;18-online publish-ahead-of-print April 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...